TABLE 1.
Sex | Female | 170 (43.7%) | |
Male | 219 (56.3%) | ||
Age | Median | Interquartile Range | |
At first sepsis | 3.4 years | 0.7–11.5 years | |
At last neuroimaging | 6.2 years | 1.8–12.8 years | |
Number of days between first sepsis and last neuroimaging | 157 days | 10–1041 days | |
Comorbidities | Category | Number (%) | |
Previously healthy | 44 (11.3%) | ||
Neurologic | Cerebral palsy/Other neurologic disease | 108 (27.8%) | |
Seizure disorder | 104 (26.7%) | ||
Developmental delay | 34 (8.7%) | ||
Ventricular shunt | 28 (7.2%) | ||
Prematurity | 24 (6.2%) | ||
Chromosomal anomaly | 13 (3.3%) | ||
Respiratory | Chronic lung disease | 59 (15.2%) | |
Airway anomaly | 33 (8.5%) | ||
Cardiovascular | Congenital heart disease | 30 (7.7%) | |
Cardiomyopathy | 12 (3.1%) | ||
Hematology/Oncology/Immunology | Stem cell transplant recipient | 55 (14.1%) | |
Liquid malignancy | 44 (11.3%) | ||
Immunodeficiency | 41 (10.5%) | ||
Solid organ transplant recipient | 40 (10.3%) | ||
Hematologic disease | 20 (5.1%) | ||
Solid organ malignancy | 15 (3.9%) | ||
Intracranial malignancy | 15 (3.9%) | ||
Sickle cell anemia | 4 (1.0%) | ||
Renal | Acute and/or chronic kidney failure | 52 (13.4%) | |
Gastrointestinal | Non-liver GI abnormality | 63 (16.2%) | |
Hepatobiliary disease | 54 (13.9%) | ||
Other | Skeletal anomaly | 35 (9.0%) | |
Endocrine anomaly | 27 (6.9%) | ||
Genitourinary anomaly | 25 (6.4%) | ||
Metabolic anomaly | 12 (3.1%) | ||
Craniofacial anomaly | 10 (2.6%) | ||
Rheumatologic disease | 5 (1.3%) |